FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy
The US Food and Drug Administration has approved Abbott’s Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy (DPN), the company announced today. As previously reported by Medscape Medical News, the FDA originally approved the system for patients with chronic pain in 2019. The device uses the company’s proprietary low-energy BurstDR stimulation waveform […]
